Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 208

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 208
---

impact our financial results of operations, cash flows and balance sheet.

Required Vote

The approval of the Equity Plan Increase Proposal requires the affirmative vote, in person or by proxy, of the majority of the voting power of the shares
present in person or represented by proxy at the meeting and entitled to vote on the subject matter. You may vote “FOR,” “AGAINST” or “ABSTAIN.” Broker non-votes, if any, will not be counted as entitled to vote on the
subject matter for this proposal and accordingly, will have no effect on the outcome of the Equity Plan Increase Proposal, and abstentions will be counted in the same manner as votes “AGAINST” the Equity Plan Increase Proposal.

THE AADI BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE EQUITY PLAN INCREASE PROPOSAL

- 144 -

PROPOSAL NO. 4:

APPROVAL OF NON-BINDINGADVISORY VOTE ON GOLDEN PARACHUTES PROPOSAL

THE AADI BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT AADI STOCKHOLDERS VOTE “FOR” THE
NON-BINDING ADVISORY VOTE ON GOLDEN PARACHUTES.

The Non-BindingAdvisory Golden Parachute Proposal

Section 14A of the Exchange Act, which was enacted as part of the Dodd-Frank Wall Street Reform and
Consumer Protection Act of 2010, requires that we provide our stockholders with the opportunity to vote to approve, on an advisory, non-binding basis, the “golden parachute” compensation arrangements
for our named executive officers, as disclosed in the table entitled “Golden Parachute Compensation” in the section of this proxy statement entitled “Executive Compensation—Quantification of Potential Payments to Certain Named Executive Officers in Connection with the Merger” beginning on page 167.

We are asking our stockholders to indicate their approval
of the various change of control payments which our named executive officers will or may be eligible to receive in connection with the Divestiture. These payments are set forth in the table entitled “Golden Parachute Compensation”
on page 167 of this proxy statement and the accompanying footnotes. The arrangements pursuant to which these compensation payments may be made have previously formed part of the our overall compensation program for its named executive officers,
which has been disclosed to our stockholders as part of the Compensation Discussion and Analysis and related sections of our annual meeting proxy statements. These historical arrangements were adopted and approved